Citric Acid Monohydrate interactions
Checked as Citric acid in this data source.
Full monograph for Citric Acid MonohydrateCheck it against another medicine
Medicines
21 documented
Mechanism
| Medicine | Severity | Mechanism | Effect | Sources |
|---|---|---|---|---|
| Aluminium Hydroxide + Magnesium Hydroxide | Major | Absorption | The concomitant administration of aluminum-containing products (e.g., antacids and phosphate binders) and citrates may significantly increase serum aluminum…2 documented mechanisms | 10 sources — open the full entry |
| Aluminium Hydroxide + Magnesium Hydroxide + Simethicone | Major | Absorption | The concomitant administration of aluminum-containing products (e.g., antacids and phosphate binders) and citrates may significantly increase serum aluminum…2 documented mechanisms | 10 sources — open the full entry |
| CiprofloxacinbaseOphthalmic | Moderate | Excretion | Urinary alkalinizers such as citrates may decrease the solubility of fluoroquinolones in the urine and increase the risk of crystalluria.2 documented mechanisms | 4 sources — open the full entry |
| Ciprofloxacin + Dexamethasone | Moderate | Excretion | Urinary alkalinizers such as citrates may decrease the solubility of fluoroquinolones in the urine and increase the risk of crystalluria.2 documented mechanisms | 4 sources — open the full entry |
| Ciprofloxacin + Hydrocortisone Acetate | Moderate | Excretion | Urinary alkalinizers such as citrates may decrease the solubility of fluoroquinolones in the urine and increase the risk of crystalluria.2 documented mechanisms | 4 sources — open the full entry |
| Clobetasol Propionate + Ofloxacin + Ornidazole + Terbinafine | Moderate | Excretion | Urinary alkalinizers such as citrates may decrease the solubility of fluoroquinolones in the urine and increase the risk of crystalluria.2 documented mechanisms | 4 sources — open the full entry |
| Dexamethasone + Levofloxacin | Moderate | Excretion | Urinary alkalinizers such as citrates may decrease the solubility of fluoroquinolones in the urine and increase the risk of crystalluria.2 documented mechanisms | 4 sources — open the full entry |
| Gatifloxacin | Moderate | Excretion | Urinary alkalinizers such as citrates may decrease the solubility of fluoroquinolones in the urine and increase the risk of crystalluria.2 documented mechanisms | 4 sources — open the full entry |
| Gatifloxacin + Dexamethasone | Moderate | Excretion | Urinary alkalinizers such as citrates may decrease the solubility of fluoroquinolones in the urine and increase the risk of crystalluria.2 documented mechanisms | 4 sources — open the full entry |
| Gemifloxacin | Moderate | Excretion | Urinary alkalinizers such as citrates may decrease the solubility of fluoroquinolones in the urine and increase the risk of crystalluria.2 documented mechanisms | 4 sources — open the full entry |
| Levofloxacin (Eye/Ear) | Moderate | Excretion | Urinary alkalinizers such as citrates may decrease the solubility of fluoroquinolones in the urine and increase the risk of crystalluria.2 documented mechanisms | 4 sources — open the full entry |
| Levofloxacin Hemihydrate | Moderate | Excretion | Urinary alkalinizers such as citrates may decrease the solubility of fluoroquinolones in the urine and increase the risk of crystalluria.2 documented mechanisms | 4 sources — open the full entry |
| Lomefloxacin | Moderate | Excretion | Urinary alkalinizers such as citrates may decrease the solubility of fluoroquinolones in the urine and increase the risk of crystalluria.2 documented mechanisms | 4 sources — open the full entry |
| Loteprednol Etabonate + Gatifloxacin | Moderate | Excretion | Urinary alkalinizers such as citrates may decrease the solubility of fluoroquinolones in the urine and increase the risk of crystalluria.2 documented mechanisms | 4 sources — open the full entry |
| Moxifloxacin HydrochlorideInjectionOphthalmicTablet | Moderate | Excretion | Urinary alkalinizers such as citrates may decrease the solubility of fluoroquinolones in the urine and increase the risk of crystalluria.2 documented mechanisms | 4 sources — open the full entry |
| Moxifloxacin Hydrochloride + Dexamethasone | Moderate | Excretion | Urinary alkalinizers such as citrates may decrease the solubility of fluoroquinolones in the urine and increase the risk of crystalluria.2 documented mechanisms | 4 sources — open the full entry |
| Moxifloxacin Hydrochloride + Xanthan Gum | Moderate | Excretion | Urinary alkalinizers such as citrates may decrease the solubility of fluoroquinolones in the urine and increase the risk of crystalluria.2 documented mechanisms | 4 sources — open the full entry |
| Nalidixic Acid | Moderate | Excretion | Urinary alkalinizers such as citrates may decrease the solubility of fluoroquinolones in the urine and increase the risk of crystalluria.2 documented mechanisms | 4 sources — open the full entry |
| Ofloxacin | Moderate | Excretion | Urinary alkalinizers such as citrates may decrease the solubility of fluoroquinolones in the urine and increase the risk of crystalluria.2 documented mechanisms | 4 sources — open the full entry |
| Ofloxacin + Clotrimazole + Beclomethasone + Lidocaine | Moderate | Excretion | Urinary alkalinizers such as citrates may decrease the solubility of fluoroquinolones in the urine and increase the risk of crystalluria.2 documented mechanisms | 4 sources — open the full entry |
| Sparfloxacin | Moderate | Excretion | Urinary alkalinizers such as citrates may decrease the solubility of fluoroquinolones in the urine and increase the risk of crystalluria.2 documented mechanisms | 4 sources — open the full entry |
This source documents no food, condition or duplication entries for Citric Acid Monohydrate.